Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) EBIT Margin (2018 - 2026)

Health Catalyst filings provide 9 years of EBIT Margin readings, the most recent being 150.48% for Q1 2026.

  • On a quarterly basis, EBIT Margin fell 12508.0% to 150.48% in Q1 2026 year-over-year; TTM through Mar 2026 was 81.71%, a 6013.0% decrease, with the full-year FY2025 number at 51.7%, down 2893.0% from a year prior.
  • EBIT Margin hit 150.48% in Q1 2026 for Health Catalyst, down from 115.27% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 17.93% in Q3 2024 to a low of 150.48% in Q1 2026.
  • Median EBIT Margin over the past 5 years was 43.66% (2023), compared with a mean of 48.57%.
  • Biggest five-year swings in EBIT Margin: skyrocketed 3357bps in 2023 and later crashed -12508bps in 2026.
  • Health Catalyst's EBIT Margin stood at 53.13% in 2022, then rose by 18bps to 43.66% in 2023, then soared by 50bps to 21.98% in 2024, then tumbled by -424bps to 115.27% in 2025, then crashed by -31bps to 150.48% in 2026.
  • The last three reported values for EBIT Margin were 150.48% (Q1 2026), 115.27% (Q4 2025), and 22.94% (Q3 2025) per Business Quant data.